The metabolic syndrome: definition, global impact, and pathophysiology (Q37617790)

21 August 2017

1 reference

title

The metabolic syndrome: definition, global impact, and pathophysiology (English)

1 reference

21 August 2017

1 reference

1 reference

Matthew V Potenza

1

1 reference

PubMed ID

19841245

21 August 2017

Jeffrey I Mechanick

series ordinal

2

1 reference

21 August 2017

1 October 2009

1 reference

Nutrition in Clinical Practice

21 August 2017

1 reference

21 August 2017

24

1 reference

21 August 2017

560-577

1 reference

21 August 2017

5

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The metabolic syndrome: prevalence in worldwide populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The metabolic syndrome: concepts and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

"Sick fat," metabolic disease, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Complementary and alternative medicine and the management of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Mediterranean diet and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Parenteral nutrition with n-3 lipids in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of flaxseed consumption on blood pressure, serum lipids, hemopoietic system and liver and kidney enzymes in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Alcohol intake, consumption pattern and beverage type, and the risk of Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

A prospective study of drinking patterns in relation to risk of type 2 diabetes among men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Moderate Alcohol Consumption, Dietary Fat Composition, and Abdominal Obesity in Women: Evidence for Gene-Environment Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Alcohol consumption and the risk of hypertension in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Antiatherogenic potential of red wine: clinician update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect on plasma insulin and plasma glucose of consuming white wine alone after a meal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Cocoa and chocolate flavonoids: Implications for cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Cinnamon improves glucose and lipids of people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of cinnamon on glucose control and lipid parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of cinnamon on A1C among adolescents with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of meal replacement on metabolic risk factors in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Hormone replacement therapy and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

A meta-analysis of the effect of soy protein supplementation on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Meta-analysis of the effects of soy protein intake on serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of dietary fibers on disturbances clustered in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Do energy density and dietary fiber influence subsequent 5-year weight changes in adult men and women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of meals with high soluble fibre, high amylose barley variant on glucose, insulin, satiety and thermic effect of food in healthy lean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Dietary fiber and body-weight regulation. Observations and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Guar gum for body weight reduction: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Weight loss associated with a daily intake of three apples or three pears among overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Nutritional factors influencing the glucose/insulin system: chromium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Role of chromium in human health and in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Chromium picolinate for reducing body weight: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Magnesium. An update on physiological, clinical and analytical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Dietary magnesium intake is related to metabolic syndrome in older Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Magnesium intake and risk of type 2 diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Traditional chinese medicine in treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Ginseng berry reduces blood glucose and body weight in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Anti-hyperglycemic effects of ginseng: comparison between root and berry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Ginseng therapy in non-insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Medicinal benefits of green tea: Part I. Review of noncancer health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Metabolically active functional food ingredients for weight control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Effects of green tea on weight maintenance after body-weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Acupuncture for obesity: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Fiber and Magnesium Intake and Incidence of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

Mediterranean Diet Inversely Associated With the Incidence of Metabolic Syndrome: The SUN prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533609342436

21 January 2018

Identifiers

DOI

10.1177/0884533609342436

1 reference

21 August 2017

1 reference

PubMed ID

19841245